Remote-Controlled Urinary Sphincter Shows Early Promise for Incontinence
A new device could make post-prostatectomy incontinence easier to manage by allowing men to control an artificial urinary sphincter remotely.
MedPage Today reports on a remote-controlled artificial urinary sphincter that has shown early promise in treating urinary incontinence in men who have had prostate cancer surgery. The device is designed to relieve incontinence while also addressing one of the most awkward aspects of existing sphincter implants.
Because this is a single early report, no independent comparisons or long-term data are available. The results should be viewed as preliminary, but the concept points toward a more discreet and patient-friendly approach to a condition that affects many men after prostate cancer treatment.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.